Dr. Scott M. Palmer, currently on faculty in the Duke University Pulmonary Division as an Associate in Medicine, proposes a structured five-year career development plan in order to develop into an independent investigator in pulmonary medicine. The proposal involves rigorous research training under an experienced physician scientist mentor, Dr. David Schwartz, who has expertise in the immunogenetics of innate immunity. Further research training is proposed under the guidance of a co-mentor with expertise in statistical genetics, a collaborator with expertise in transplant immunology, and complemented by didactic graduate coursework. The overall goal of the proposed research is to understand how innate immune responses contribute to the development of posttransplant bronchiolitis obliterans syndrome (BOS). We hypothesize that genetic, physiological or biological differences in innate immune responsiveness will significantly alter the risk for the development of BOS after lung transplant. This novel hypothesis is clinically relevant based on the high rate of posttransplant death due to BOS, scientifically relevant because of the incomplete understanding of the pathophysiology of BOS, and supported by several basic and clinical observations. We and others have recently demonstrated that significant polymorphisms exist in innate immune receptor genes, and that these differences significantly alter subsequent inflammatory and immune responses. In order to test our hypothesis, we will characterize polymorphisms in donor and recipient toll-like receptor-2 (TLR2), TLR4, and CD14 genes, and phenotypically characterize the airway physiological and biological response to endotoxin in a cohort of 120 lung transplant recipients. We will prospectively capture clinical information on the cohort and determine the predictive importance of innate genetic, physiological, or biological factors on the development or progression of BOS in a multivariate model. At the conclusion of the career development award, Dr. Palmer will have gained considerable expertise in study design, basic genetic analyses, transplant immunology, and statistical analyses. He will apply these skills to direct future investigations of patient oriented research problems in pulmonary medicine.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-F (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Wahidi, Momen M; Willner, Daniel A; Snyder, Laurie D et al. (2009) Diagnosis and outcome of early pleural space infection following lung transplantation. Chest 135:484-491
Waggoner, Jesse; Martinu, Tereza; Palmer, Scott M (2009) Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant. J Heart Lung Transplant 28:395-8
Kinnier, C V; Eu, J P C; Davis, R D et al. (2008) Successful bilateral lung transplantation for lymphangiomatosis. Am J Transplant 8:1946-50
Reams, B D; Musselwhite, L W; Zaas, D W et al. (2007) Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. Am J Transplant 7:2802-8
Garantziotis, Stavros; Palmer, Scott M; Snyder, Laurie D et al. (2007) Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide. Transplantation 84:1012-9
Palmer, S M; Klimecki, W; Yu, L et al. (2007) Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. Am J Transplant 7:693-9
Palmer, Scott M; Burch, Lauranell H; Mir, Saad et al. (2006) Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 20:30-6
Palmer, Scott M; Burch, Lauranell H; Trindade, Anil J et al. (2005) Innate immunity influences long-term outcomes after human lung transplant. Am J Respir Crit Care Med 171:780-5
Palmer, Scott M; Burch, Lauranell H; Davis, R Duane et al. (2003) The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 168:628-32